home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505d.zip
/
M9550829.TXT
< prev
next >
Wrap
Text File
|
1995-03-25
|
2KB
|
40 lines
Document 0829
DOCN M9550829
TI Bacillus Calmette-Guerin complications in children born to
HIV-1-infected women with a review of the literature.
DT 9505
AU O'Brien KL; Ruff AJ; Louis MA; Desormeaux J; Joseph DJ; McBrien M;
Coberly J; Boulos R; Halsey NA; Department of International Health,
School of Hygiene and Public; Health, Johns Hopkins University,
Baltimore, MD.
SO Pediatrics. 1995 Mar;95(3):414-8. Unique Identifier : AIDSLINE
MED/95166595
AB OBJECTIVE. To compare the risk of complications following Bacillus
Calmette-Guerin (BCG) vaccination among children by maternal and infant
HIV-1 infection status as part of an investigation of an outbreak of BCG
complications. METHODS. A nonconcurrent cohort study of BCG
complications among 125 infants born to HIV-1 seropositive and 166
infants born to HIV-1 seronegative mothers was conducted in Cite Soleil,
Haiti. Infants were examined at regular intervals until 15 months of
age, and complications from BCG were documented. An investigation of BCG
vaccination practices was conducted. RESULTS. Mild or moderate
complications occurred among 16 of 166 (9.6%) infants born to HIV-1
seronegative mothers compared with 4 of 13 HIV-1-infected infants
(30.8%, P = .04) and 10 of 75 (13.3%, P = .39) uninfected infants born
to HIV-1-infected mothers. No serious complications were noted. The
outbreak of complications was associated with administration of 2.0 to
2.5 times the recommended dose of BCG vaccine. CONCLUSIONS. This and
five other cohort studies indicate that there may be a small increased
risk of complications following BCG vaccination among HIV-1-infected
children, but the reactions are usually mild and the risk does not
outweigh the benefits of BCG vaccination in populations at high risk of
tuberculosis during infancy and childhood.
DE Adult BCG Vaccine/*ADVERSE EFFECTS Cohort Studies Disease
Transmission, Vertical Female Human *HIV Infections/TRANSMISSION HIV
Seronegativity *HIV Seropositivity Infant Infant, Newborn Support,
U.S. Gov't, P.H.S. JOURNAL ARTICLE REVIEW REVIEW OF REPORTED CASES
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).